J 2005

Treatment of acute agitation in psychotic disorders

MOHR, Pavel, Ján PEČEŇÁK, Jaromír ŠVESTKA and T. TREUER

Basic information

Original name

Treatment of acute agitation in psychotic disorders

Name in Czech

Diskuse o léčbě akutního psychotického onemocnění

Authors

MOHR, Pavel, Ján PEČEŇÁK, Jaromír ŠVESTKA and T. TREUER

Edition

Neuroendocrinology Letters, Sweden, Stockholm, Maghira and Maas Publications, 2005, 0172-780X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30000 3. Medical and Health Sciences

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 1.005

Organization unit

Faculty of Medicine

UT WoS

000233233000013

Keywords in English

agitation; schizophreni; second generation antipsychotics; olanzapine; ziprasidone
Změněno: 30/6/2009 10:52, prof. MUDr. Eva Češková, CSc.

Abstract

V originále

Several psychotic disorders, including schizophrenia, may be associated with symptoms of acute agitation and aggression. While drug treatment of agitation is often essential, non-pharmacological interventions, both environmental and behavioral, also play important roles in the complex management of agitated patients. The most extensively used psychotropic drugs are parenteral. formulas of conventional antipsychotics and benzodiazepines. Recently, injection forms of two second generation antipsychotics, olanzapine and ziprasidone, have become available. Both drugs have shown adequate efficacy and tolerability in several double-blind trials of intramuscular administration in acutely agitated psychotic patients. Compared to conventional medication, injection forms of the new antipsychotics may have a faster onset of action and more favorable profile of adverse events. Alternative approaches to injection administration include liquid drug formula, orally disintegrating tablets and wafers, treatment initiation with high doses, or rapid dose escalation. Evidence suggests that second-generation antipsychotics should be among the first-line choices in the treatment of agitation in acute psychosis.

In Czech

Článek popisuje zkušenosti a výstupy z odborných studií, prováděných na psychiatrických klinikách v různých zemích. Nabízí různé pohledy a diskusi